Gelonghui, March 20 | China Resources Healthcare (1515.HK) is now up 3.61% to HK$4.02, temporarily trading HK$14.86 million, with a current market value of HK$5.2 billion. China Resources Medical announced its annual results for the year ended December 31, 2023 yesterday evening. During the period, it achieved revenue of 10.108 billion yuan (RMB, same below), an increase of 27.9% over the previous year. Owners of the parent company should account for an annual profit of $258 million, and holders of common equity interests in the parent company should account for $0.20 per share (basic and diluted). It is recommended to distribute a final dividend of $0.06 per share. During the reporting period, the hospital business turnover was 9.406 billion yuan, an increase of 33.4% over the previous year. Among them: (1) the turnover of Liao Jianbiao and Hejiang Energy Biao during the reporting period was 4,096 billion yuan; and (2) the turnover of existing hospitals during the reporting period was 5.310 billion yuan, an increase of 11.2% over the previous year. The increase was mainly due to the increase in the number of patients treated and the increase in bed usage.